Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: Analysis of clinicobiologic correlations in 105 patients

Leukemia and Lymphoma

Volumn 53, Issue 1, 2012, Pages 83-88

  Cavazzini, Francesco ^a   Rizzotto, Lara ^a   Sofritti, Olga ^a   Daghia, Giulia ^a   Cibien, Francesca ^a   Martinelli, Sara ^a   Ciccone, Maria ^a   Saccenti, Elena ^a   Dabusti, Melissa ^a   Elkareem, Abbas Awad ^a   Bardi, Antonella ^a   Tammiso, Elisa ^a   Cuneo, Antonio ^a   Rigolin, Gian Matteo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Chemorefractory disease; Chronic lymphocytic leukemia; Clonal evolution; Cytogenetics; IGH translocation

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; CENTROMERE; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 17P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CLONAL EVOLUTION; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE PROBE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 14; CLONAL EVOLUTION; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TIME FACTORS; TRANSLOCATION, GENETIC; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84855435696     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.606384     Document Type: Article

References (33)

1. Döhner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343: 1910-1916. (Pubitemid 32064784)
2. H aferlach C, Dicker F, Schnittger S, et al. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 2007;21:2442-2451. (Pubitemid 350148886)
3. Cuneo A, Bigoni R, Castoldi G. Towards a clinically relevant cytogenetic classification of chronic lymphocytic leukemia and related disorders. Haematologica 1998;83:577-579. (Pubitemid 28364067)
4. Nowell PC, Moreau L, Growney P, et al. Karyotypic stability in chronic B-cell leukemia. Cancer Genet Cytogenet 1988;33:155-160.
5. J uliusson G, Robèr t KH, Ost A, et al. Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma. Blood 1985;65:134-141. (Pubitemid 15191049)
6. Cuneo A, Bigoni R, Rigolin GM, et al. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance. Haematologica 2002;87:44-51. (Pubitemid 34101112)
7. C hevallier P, Penther D, Avet-Loiseau H, et al. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. Br J Haematol 2002;116:142-150. (Pubitemid 34122071)
8. S hanafelt TD, Witzig TE, Fink SR, et al. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol 2006;24: 4634-4634.
9. S tilgenbauer S, Sander S, Bullinger L, et al. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica 2007;92:1242-1245. (Pubitemid 350144184)
10. H jalmar V, Hast R, Kimby E. Sequential fluorescence in situ hybridization analyses for trisomy 12 in chronic leukemic B-cell disorders. Haematologica 2001;86:174-180. (Pubitemid 32216091)
11. C uneo A, Roberti MG, Bigoni R, et al. Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21. Br J Haematol 2000;108:559-564. (Pubitemid 30196253)
12. Q iu HX, Xu W, Cao XS, et al. Cytogenetic characterization in Chinese patients with chronic lymphocytic leukemia: a prospective, multicenter study on 143 cases analysed with interphase fluorescence in situ hybridisation. Leuk Lymphoma 2008;49:1887-1892.
13. C avazzini F, Hernandez JA, Gozzetti A, et al. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis. Br J Haematol 2008;142:529-523.
14. H aferlach C, Dicker F, Weiss T, et al. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters. Genes Chromosomes Cancer 2010;49:851-859.
15. M atutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994;8:1640-1645. (Pubitemid 24323778)
16. C uneo A, Rigolin GM, Bigoni R, et al. Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis. Leukemia 2004;18:476-483. (Pubitemid 38425861)
17. Rigolin GM, Maff ei R, Rizzotto L, et al. Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance. Cancer 2010;116:1926-1937.
18. C heson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990-4997.
19. R ai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219-234.
20. D eambrogi C, Cresta S, Cerri M, et al. 14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia. Br J Haematol 2009;144:131-133.
21. H aferlach C, Dicker F, Schnittger S, et al. Translocation involving the IGH@ locus occur in 3.7% of chronic lymphocytic leukemia and are associated with unmutated IGHV status and shorter time to treatment: a study on 2,135 cases. Blood 2010;116(Suppl. 1): Abstract 1480.
22. Matutes E, Attygalle A, Wotherspoon A, et al. Diagnostic issues in chronic lymphocytic leukaemia (CLL). Best Pract Res Clin Haematol 2010;23:3-20.
23. Cuneo A, Bardi A, Wlodarska I, et al. A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma. Leukemia 2001;15:1262-1267. (Pubitemid 32776451)
24. Nowakowski GS, Dewald GW, Hoyer JD, et al. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol 2005;130:36-42. (Pubitemid 40979130)
25. Nguyen-Khac F, Lesty C, Chapiro E, et al. Specific chromosomal IG translocations have diff erent prognosis in chronic lymphocytic leukemia. Blood 2010;116(Suppl. 1): Abstract 582.
26. M essmer BT, Messmer D, Allen SL, et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005;115:755-764. (Pubitemid 40322252)
27. van Gent R, Kater AP, Otto SA, et al. In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow. Cancer Res 2008;68:10137-10144.
28. Herishanu Y, Pér ez-Galá n P, Liu D, et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-{kappa}B activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 2011;117:563-574.
29. F lanagan MB, Sathanoori M, Surti U, et al. Cytogenetic abnormalities detected by fluorescence in situ hybridization on paraffin-embedded chronic lymphocytic leukemia/small lymphocytic lymphoma lymphoid tissue biopsy specimens. Am J Clin Pathol 2008;130:620-627.
30. C hesi M, Kuehl WM, Bergsagel PL. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma. Ann Oncol 2000;11(Suppl. 1):131-135.
31. Pospisilova H, Baens M, Michaux L, et al. Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL. Leukemia 2007;21:2079-2083. (Pubitemid 47299996)
32. Wlodarska I, Matthews C, Veyt E, et al. Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events. J Mol Diagn 2007;9:47-54. (Pubitemid 47322013)
33. R eindl L, Bacher U, Dicker F, et al. Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms. Br J Haematol 2010;151:25-36.